Although the country is moving closer to achieving its ambitious goal of universal health insurance coverage for all Mexican citizens, some obstacles still remain. The public health sector will require greater investment to meet key objectives set out in the National Health Plan 2019-24, while the question of how to address the rural-urban divide remains. Neither of these problems will likely be helped through increased budget cuts at the national level. The pharmaceutical and medical devices industries remain potential bright spots as multinational companies move their practices to Mexico to avoid import duties. Meanwhile, efforts to boost the private insurance penetration rate presents an investment opportunity that could help strengthen the industry. This chapter contains an interview with Rodrigo Puga, Country Manager, Pfizer.

Cover of The Report: Mexico 2019

The Report

This chapter is from the Mexico 2019 report. Explore other chapters from this report.

Interviews & Viewpoints

Sketch of Miguel Torruco Marqués, Minister of Tourism
Rodrigo Puga, Country Manager, Pfizer: Interview

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart